Explorative analysis of cytokine expression bei chronic venous disease and insufficiency

Explorative analysis of cytokine expression bei chronic venous disease and insufficiency - EAZE-V

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00033022

Enrollment

Registered

2025-04-04

Start date

2025-03-28

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I83.9 I83.2

Interventions

Group 1: Patients with chronic venous disease or insufficiency

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Chronic venous insufficiency, Stages C2/C4/C6

Exclusion criteria

Exclusion criteria: Antikoagulant Active malignancy Adipositas grade = 1 Relevant comorbities Chronic autoimmune disorders History of deep vein thrombosis

Design outcomes

Primary

Measure	Time frame
Differential cytokine expression in serum on day of examination using multiplex assays once recruitment is complete.	—

Secondary

Measure	Time frame
Quality of life Questionnaire (FLQA-VS10)	—

Countries

Germany

Contacts

Public ContactSören Dräger

Universitätsklinikum Schleswig-Holstein, Klinik für Dermatologie

soeren.draeger@uksh.de0451 500 41550

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Apr 4, 2026